Newborn Screening Market Share, Trends, and Analysis by 2030
Newborn Screening Market: Size and Share
-
CAGR (2022 - 2030)9.40% -
Market Size 2022
US$ 1,206.74 Million -
Market Size 2030
US$ 2,484.16 Million
Market Dynamics
- Advancements in Methods for Screening Infants for Genetic Disorders hold Immense Potential for the Overall Newborn Screening Market
- Rising Burden of Congenital Diseases Leads to an Increase in Demand for Newborn Screening
- Integration of Machine Learning and Artificial Intelligence (AI) in Screening
Market Segmentation
- Reagents and Assay Kits Instruments
- Tandem Mass Spectrometry
- Molecular Assays
- Immunoassays and Enzymatic Assays
- Pulse Oximetry Screening Technology
- Dry Blood Spot Test
- Hearing Screen Test
- Critical Congenital Heart Diseases Test
- Hospitals and Clinics
- Diagnostic Laboratories
Newborn Screening Market Players Density: Understanding Its Impact on Business Dynamics
The Newborn Screening Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Newborn Screening Market are:
- LifeCell International Pvt Ltd
- Zentech SA
- Trivitron Healthcare Pvt Ltd
- PerkinElmer Inc
- Waters Corp
- Bio-Rad Laboratories Inc.
Disclaimer: The companies listed above are not ranked in any particular order.
- Get the Newborn Screening Market top key players overview